The reduction in the rating for NHL from 100 percent to 40 percent, effective March 1, 2018, was proper.
The deciding factor: The evidence did not show a local reoccurrence or metastasis of the disease and the Veteran's NHL has remained in unmaintained remission since his chemotherapy treatment in approximately 2002/2003.
- Claimed conditions
- Residuals of non-Hodgkin's lymphoma (NHL), Peripheral neuropathy of the bilateral lower extremity
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- January 9, 2023
- Citation
- 23001289
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for service connection of peripheral neuropathy and sleep apnea, as well as a TDIU claim, to ensure compliance with the Joint Motion for Remand.
- Granted
The Board granted service connection for obstructive sleep apnea, effective from the date of the February 2025 rating decision.
- Remanded (sent back)
The Board remands the claim for a medical examination to determine if the Veteran's current neck strain is related to his in-service activities.
- Remanded (sent back)
The Board remands the claim for a rating in excess of 70 percent for PTSD due to an inadequate medical opinion.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.